The role of high-dose corticosteroids in the treatment of chronic lymphocytic leukemia

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.7, 2012-07, pp. : 1009-1017

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The current role of high-dose imatinib in chronic myeloid leukemia patients, newly diagnosed or resistant to standard dose

By Breccia Massimo Alimena Giuliana

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2075-2087

Informa Healthcare

Access to resources Recommend Favorite

Evolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemia

By Kharfan-Dabaja Mohamed A Fahed Rabih Hussein Mohamad Santos Edgardo S

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 11, 2007-11 ,pp. : 1799-1815

Informa Healthcare

Access to resources Recommend Favorite

Bendamustine for treatment of chronic lymphocytic leukemia

By Chang Julie Elizabeth Kahl Brad Steven

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1495-1505

Informa Healthcare

Access to resources Recommend Favorite

Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3389-3398

Bentham Science Publishers

Access to resources Recommend Favorite

New treatment options for chronic lymphocytic leukemia

By Delgado Julio Baumann Tycho Santacruz Rodrigo Montserrat Emili

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 823-832

Informa Healthcare

Access to resources Recommend Favorite